Setting The Bar High For Generic Medicines

Setting The Bar High For Generic Medicines

The Dhaka, Bangladesh-based pharmaceuticals company is leveraging its expertise to fight the Covid-19 pandemic. As the pandemic upended the healthcare supply chain over the past year, one company in Bangladesh did not only strive to ensure the continued distribution of medicines across the country, but also introduced its own antidote against Covid-19. In the midst of the unprecedented health crisis, Dhaka, Bangladesh-based Beximco Pharmaceuticals introduced remdesivir, the world's first antiviral drug approved by the U. S. Food and Drug Administration to treat those infected by the Covid-19 virus. Originally developed by U. S.-based Gilead Sciences, Beximco sells the generic drug under the brand name Bemsivir. The company, which is a leading manufacturer and exporter of generic drugs, provided Bemsivir shots free to all government-designated Covid-19 hospitals in Bangladesh and donated large quantities of the medicine to several countries, including India, on humanitarian grounds. "From the very beginning of this pandemic, Beximco Pharma has made an all-out effort to improve access to all repurposed drugs by ramping up their production in the quickest possible time," says Nazmul Hassan MP, Managing Director & Chief Executive Officer of Beximco Pharma. "Despite tremendous challenges, Beximco has worked to ensure the uninterrupted supply of medicines